Modufolin (arfolitixorin)

News alerts, weekly reports and conference planners

Company:

Isofol Medical, Solasia

Drug class:

Thymidylate synthase inhibitor

Related drugs:

No biomarker	Colorectal Cancer	No biomarker	Colorectal Cancer	arfolitixorin Sensitive: B - Late Trials arfolitixorin Sensitive : B	arfolitixorin Sensitive: B - Late Trials arfolitixorin Sensitive : B
TYMS underexpression	Colorectal Cancer	TYMS underexpression	Colorectal Cancer	arfolitixorin Sensitive: C3 – Early Trials arfolitixorin Sensitive : C3	arfolitixorin Sensitive: C3 – Early Trials arfolitixorin Sensitive : C3

Associations
(2)